» Articles » PMID: 33017219

Oral and Intestinal Microbial Features in Pregnant Women with Hypothyroidism and Their Correlations with Pregnancy Outcomes

Overview
Date 2020 Oct 5
PMID 33017219
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to explore the characteristics of oral and intestinal microbiota of pregnant women with hypothyroidism during pregnancy, and to find the correlations between the changes of flora and pregnancy outcome of pregnant women with hypothyroidism during pregnancy. In this study, oral and intestinal microbial composition was surveyed by using the 16S rRNA sequencing approach in 61 pregnant women (30 with hypothyroidism and 31 normal controls). Sequentially, we validated the differential microbial features by using the quantitative real-time PCR (qPCR) approach in 10 randomly selected pregnant women (5 with hypothyroidism and 5 normal controls). Furthermore, general clinical data and serological indices were added to the analysis to examine the links between oral and intestinal microbiota and pregnancy outcomes. The 16S rRNA results showed that the relative abundances of were higher in pregnant women in the hypothyroidism group than in those in the control group, whereas the levels of were higher in the control group than in the hypothyroidism group. The serum C-reactive protein level, the weight gain during pregnancy, and the incidence of fetal distress were higher in the hypothyroidism group than in the control group. The QPCR results also showed the same changes of the intestinal microbiota in the two groups. There were significant differences in the oral and intestinal microbiota between pregnant women with hypothyroidism and normal pregnant women. The changes of microbiota is one of the factors influencing the occurrence and development of hypothyroidism during pregnancy.

Citing Articles

Unveiling the Role of Gut Microbiota and Metabolites in Autoimmune Thyroid Diseases: Emerging Perspectives.

Yan K, Sun X, Fan C, Wang X, Yu H Int J Mol Sci. 2024; 25(20).

PMID: 39456701 PMC: 11507114. DOI: 10.3390/ijms252010918.


Oral Microbiota of Infants in Maternal Gestational Diabetes: A Systematic Review.

Camoni N, Conti G, Majorana A, Bardellini E, Salerno C, Wolf T Children (Basel). 2024; 11(4).

PMID: 38671638 PMC: 11049358. DOI: 10.3390/children11040421.


Evaluation of the therapeutic efficacy of different doses of LT4 in pregnant women with high-normal TSH levels and TPOAb positivity in the first half of pregnancy.

Tian X, Xu Y, Ban Y, Li J, Hu L, Liu D Lipids Health Dis. 2024; 23(1):101.

PMID: 38600581 PMC: 11005176. DOI: 10.1186/s12944-024-02099-9.


The Dynamic Changes in the Composition and Diversity of Vaginal Microbiota in Women of Different Pregnancy Periods.

Hu F, Sun X, Su Y, Huang M Microorganisms. 2023; 11(11).

PMID: 38004698 PMC: 10673304. DOI: 10.3390/microorganisms11112686.


Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases.

Mendoza-Leon M, Mangalam A, Regaldiz A, Gonzalez-Madrid E, Rangel-Ramirez M, Alvarez-Mardonez O Front Endocrinol (Lausanne). 2023; 14:1192216.

PMID: 37455925 PMC: 10349397. DOI: 10.3389/fendo.2023.1192216.